ロード中...
A phase II study to evaluate the safety and efficacy of topical 3% amphotericin B cream (Anfoleish) for the treatment of uncomplicated cutaneous leishmaniasis in Colombia.
BACKGROUND:Pentavalent antimonials (Sb5) are the first-line drugs for treating cutaneous leishmaniasis in Colombia; however, given problems with toxicity, compliance, availability, and cost, it is imperative to look for better therapeutic options. Intravenous amphotericin B (AmB) has been used exten...
保存先:
| 主要な著者: | , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Public Library of Science (PLoS)
2018-07-01
|
| シリーズ: | PLoS Neglected Tropical Diseases |
| オンライン･アクセス: | http://europepmc.org/articles/PMC6078324?pdf=render |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|